Zeo ScientifiX, Inc.

false 0001557376 0001557376 2026-07-08 2026-07-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 8, 2026 ZEO SCIENTIFIX, INC. (Exact name of registrant as specified in its charter) Nevada 000-55008 47-4180540 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3321 College Avenue , Suite 246 Davie , Florida 33314 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (888) 963-7881 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered None N/A N/A Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ As used in this Current Repo rt on Form 8-K (this “ Current Report ”), and unless otherwise indicated, the terms “ the Company ,” “ ZEO ,” “ we ,” “ us ” and “ our ” refer to Zeo ScientifiX, Inc. Item 2.02 Results of Operations and Financial Condition. The disclosure set forth in Item 7.01 of this Current Report is incorporated herein by reference. Item 7.01 Regulation FD Disclosure. On January 13, 2026, the Company issued a press release announcing that it had reported exceptional year-over-year revenue growth, stronger gross margins, and improved operating performance in its recently filed Form 10-Q for the Quarter ended April 30, 2026. A copy of the press release is included with this Current Report as Exhibit 99.1 . Regulation FD Disclosure The information set forth in Items 2.02 and 7.01 of this Current Report and in the press release included as Exhibit 99.1 to this Current Report is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report and in the press release included as Exhibit 99.1 to this Current Report shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended (the “ Securities Act ”), regardless of any general incorporation language in such filing. Forward-Looking Statements This Current Report and the press release included as Exhibit 99.1 to this Current Report contains statements which should be considered forward-looking statements within the meaning of the Securities Act, the Exchange Act and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known a nd unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Actual results could vary dramatically. You should not place undue reliance on forward-looking statements. ZEO has no intention and specifically disclaims any duty to update the information in this press release. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated July 8, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 8, 2026 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Chief Executive Officer and Chief Financial Officer 2